You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 45 No. 5, May 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Lymphocyte β-Adrenergic Receptor Modification in Bulimia

Neil S. Buckholtz, PhD; David T. George, MD; Albert O. Davies, MD; David C. Jimerson, MD; William Z. Potter, MD, PhD

Arch Gen Psychiatry. 1988;45(5):479-482.


Abstract

• β-Adrenergic receptor binding on circulating lymphocytes was evaluated in young female bulimic patients (n =12) and age- and sex-matched normal control volunteers (n =10). Using iodine 125—labeled cyanopindolol, antagonist binding was evaluated (number of receptors [Bmax] and dissociation constant [KD]), and using isoproterenol competition of cyanopindolol binding, the concentration required to inhibit binding by 50% (IC50) for isoproterenol and the agonist affinity measure of KL/KH (ratio of dissociation constants for the low- and highaffinity states of the receptor) were determined. Plasma norepinephrine (NE) level was also measured. There was a trend toward lower plasma NE levels in the bulimic patients. The KL/KH ratio in bulimic patients was significantly greater than that for the normal volunteers, indicating increased receptor coupling. The KL/KH ratio was not significantly correlated with plasma NE level. Neither Bmax nor KD was different between the two groups. These findings suggest that β-adrenergic receptors in bulimic patients may be more responsive than in normal subjects, without alteration of the traditional measures of receptor responses, a difference that cannot be explained on the basis of plasma NE. These findings provide another line of evidence for altered regulation of the noradrenergic system in bulimic patients during a controlled phase of their illness.



Author Affiliations

From the Sections on Clinical Pharmacology (Drs Buckholtz and Potter) and Biomedical Psychiatry (Drs George and Jimerson), Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Md; and the Department of Medicine, Baylor College of Medicine, Houston (Dr Davies).


Footnotes

Accepted for publication Nov 25, 1987.

Read before the 139th Annual Meeting, American Psychiatric Association, Washington, DC, May 12, 1986.

Reprint requests to National Institute of Mental Health, Parklawn Bldg, Room 9C-26, 5600 Fishers Lane, Rockville, MD 20857 (Dr. Buckholtz).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Low Serotonin and Dopamine Metabolite Concentrations in Cerebrospinal Fluid From Bulimic Patients With Frequent Binge Episodes
Jimerson et al.
Arch Gen Psychiatry 1992;49:132-138.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.